We have completed over 25 transactions, worth approximately $4.9B since 2010 across therapeutic areas, stage of development, modality and geography. Our success is attributed to four (4) core pillars that help define our advisory practice, function as key differentiators and are core elements for success.
For over 20 years, the Managing Directors have been cultivating relationships with C-Level executives, Franchise Heads, VP’s, Directors and other key stakeholders within biopharma and the life sciences.
We are afforded unique insight that can substantiate and quantify deal value through our core expertise in our consulting practice.
Our process is designed and implemented to increase the likelihood of success and to further increase deal value in a time sensitive environment.
We have significant experience and expertise through all facets of deal execution ranging from initial planning and preparation, to negotiating non-binding and binding agreements.
Destum Partners either represents the seller or the buyer. We are therapeutic area agnostic, open to various stages of development from early pre-clinical to commercial, and our geographic reach is global. Our deal type focus is: